October 5th, 2015
•The goal of this protocol is to manufacture pathogen-specific clinical-grade T cells using a bench-top, automated, second generation cell enrichment device that incorporates a closed cytokine capture system and does not require dedicated staff or use of a GMP facility. The cytomegalovirus pp65-specific-T cells generated can be directly administered to patients.
Tags
Vídeos Relacionados
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Following Cell-fate in E. coli After Infection by Phage Lambda
piggyBac Transposon System Modification of Primary Human T Cells
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Monitoring Dendritic Cell Migration using 19F / 1H Magnetic Resonance Imaging
Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets
Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados